Home/Filings/4/0001104659-23-041721
4//SEC Filing

Davis Krista 4

Accession 0001104659-23-041721

CIK 0001023024other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 8:01 PM ET

Size

16.3 KB

Accession

0001104659-23-041721

Insider Transaction Report

Form 4
Period: 2023-02-28
Davis Krista
SVP, CHIEF HR OFFICER
Transactions
  • Award

    Common Stock

    2023-02-28+8,10436,695 total
  • Award

    Common Stock

    2023-02-28+12,15828,591 total
Footnotes (2)
  • [F1]Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023.
  • [F2]These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001946439

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:01 PM ET
Size
16.3 KB